Cardiolipin binding
This studies how a peptide binds to a special fat molecule in the mitochondrial membrane and supports its stability, similar to a repair clamp on a damaged structure. Cell stress markers and mitochondrial function are measured.
Cardiolipin binding
Also known as: SS-31 · Forzinity
The essentials at a glance
Binds mitochondrial cardiolipin; accelerated U.S. approval covers a narrowly defined rare disease.
Distinction: Elamipretide is approved for a narrowly defined rare disease, unlike the unregulated MOTS-c.
The described biological role is well established, or extensive regulator-reviewed human data exist for clearly defined products and uses. This does not automatically transfer to other products or purposes.
Approved for specific uses: Prescription active ingredient for defined indications in at least one jurisdiction; not offered here.
Research questions
This studies how a peptide binds to a special fat molecule in the mitochondrial membrane and supports its stability, similar to a repair clamp on a damaged structure. Cell stress markers and mitochondrial function are measured.
Researchers study how a peptide interacts with the cell's power plants, the mitochondria, and affects their energy production. Measures include oxygen consumption and energy turnover in cell models.
Researchers study how cells produce and use energy, particularly through the mitochondria, similar to measuring how efficiently an engine burns fuel. Typical measures include oxygen consumption and energy output in cell models.
Simple example
Think of it like a product that has gone through a defined review process, similar to a vehicle that has passed a technical inspection.
Even approval covers only the reviewed indication and dosing regimen and does not guarantee an individual outcome.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.
Combinations of growth-axis, mitochondrial, and skin peptides are compared here with the goal of influencing visible or felt signs of ageing, often documented personally over years. Anecdotes and vendor advertising about slowed ageing are not scientific proof.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
The accelerated approval covers only the specific indication.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.